Innovative approaches to targeted drug discovery: From molecular design to therapeutic application
Targeted anticancer drugs, including CDK4/6 inhibitors, PARP inhibitors and PI3K inhibitors, have considerably improved outcomes in cancer treatment. However, their clinical application is still challenged by significant interindividual pharmacokinetic variability. This may lead to differences in drug efficacy and toxi...